Creative Biolabs sets July 14 webinar on iPSC brain models and neurodegeneration

By AI, Created 6:16 AM UTC, June 05, 2026, /AGP/ – Creative Biolabs will host a July 14, 2026 webinar on how iPSC-derived human brain tissue models can reveal genetic, cellular and vascular drivers of neurodegenerative disease. The event features Mount Sinai neuroscientist Joel W. Blanchard and focuses on mechanisms linked to Parkinson’s and Alzheimer’s disease.

Why it matters: - Neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease still lack a full explanation for why some cells and patients are more vulnerable than others. - Human iPSC-derived brain tissue models are becoming a more physiologically relevant way to study those disease mechanisms. - The webinar is aimed at researchers working in neuroscience, stem cell biology, translational medicine and drug discovery.

What happened: - Creative Biolabs announced an upcoming webinar titled “Decoding the Mechanisms Underlying Susceptibility to Neurodegeneration with iPSC-Derived Human Brain Tissue.” - The webinar is scheduled for 10:00 AM EDT on July 14, 2026. - Joel W. Blanchard, PhD, will present during the event. - Blanchard is an associate professor in the Nash Family Department of Neuroscience and the Department of Cell, Developmental & Regenerative Biology at the Icahn School of Medicine at Mount Sinai. - Registration is available through the webinar page.

The details: - Blanchard’s research program focuses on how genetic and environmental factors contribute to neurodegeneration through stem cell-derived human brain models. - The presentation will examine multicellular human brain tissue models and how they can surface pathways tied to degeneration. - One example involves a rare genetic mutation linked to severe juvenile Parkinson’s disease. - That mutation points to a lysosome-polyamine-epigenetic axis involved in neurodegeneration. - A second example looks at APOE4 and its role in promoting α-synuclein co-pathology. - That finding connects glial dysfunction with faster neurodegenerative progression. - A third example shows how APOE4 drives cerebrovascular remodeling and blood-brain barrier dysfunction in Alzheimer’s disease. - The vascular findings add to evidence that neurodegeneration is not only a neuronal problem.

Between the lines: - The webinar reflects a broader shift in neurodegeneration research toward human-relevant model systems instead of relying only on traditional animal or simplified cell models. - The focus on APOE4 suggests continued interest in common genetic risk factors that may influence both neuronal and non-neuronal disease pathways. - The mix of genetic, glial and vascular examples signals an increasingly multi-system view of brain disease.

What’s next: - Creative Biolabs will host the webinar on July 14 and use the session to highlight current work in human brain tissue modeling. - Attendees are expected to hear how stem cell engineering, organoid technology and functional genomics are being applied to disease progression, aging and therapeutic response. - The event is positioned for scientists looking for new tools to study neurodegenerative disease mechanisms in human tissue models.

The bottom line: - Creative Biolabs is using the webinar to showcase iPSC-derived brain tissue as a key platform for probing why neurodegeneration starts, spreads and worsens.